Celcuity Inc. (CELC)

5d ago, source: Yahoo Finance

MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that ...

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

28d ago, source: Business Insider

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the fourth quarter and full year ...

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

21d ago, source: Business Insider

MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that ...

Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript

23d ago, source: Insider Monkey

Celcuity Inc. beats earnings expectations. Reported EPS is $-0.65, expectations were $-0.71. CELC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see ...

Celcuity Stock (NASDAQ:CELC), Analyst Ratings, Price Targets, Predictions

28d ago, source: Benzinga.com

There is no last upgrade for Celcuity.

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

29d ago, source: Stockhouse

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the fourth quarter and full year ...

Celcuity Inc. (CELC) Q4 2023 Earnings Call Transcript

28d ago, source: Seeking Alpha

Good afternoon, ladies and gentlemen, and welcome to the Celcuity Fourth Quarter and Year-End Financial Results Conference Call. At this time, all lines are in a listen-only mode. Following the ...

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

28d ago, source: Yahoo Finance

MINNEAPOLIS, March 27, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced ...

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides ...

29d ago, source: The Bakersfield Californian

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the fourth quarter and full year ...